BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21865109)

  • 1. CT, MRI and PET imaging in peritoneal malignancy.
    Patel CM; Sahdev A; Reznek RH
    Cancer Imaging; 2011 Aug; 11(1):123-39. PubMed ID: 21865109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State-of-the-art imaging of peritoneal carcinomatosis].
    Pfannenberg C; Schwenzer NF; Bruecher BL
    Rofo; 2012 Mar; 184(3):205-13. PubMed ID: 22198834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT.
    Schmidt S; Meuli RA; Achtari C; Prior JO
    Clin Nucl Med; 2015 May; 40(5):371-7. PubMed ID: 25783507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
    Anthony MP; Khong PL; Zhang J
    AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
    Soussan M; Des Guetz G; Barrau V; Aflalo-Hazan V; Pop G; Mehanna Z; Rust E; Aparicio T; Douard R; Benamouzig R; Wind P; Eder V
    Eur Radiol; 2012 Jul; 22(7):1479-87. PubMed ID: 22358428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET and PET-CT imaging findings of peritoneal and omental involvement in patients with lymphoma.
    Karaosmanoglu AD; Butros SR; Scott J; Blake MA
    Clin Imaging; 2013; 37(6):1089-93. PubMed ID: 23938141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
    Dirisamer A; Schima W; Heinisch M; Weber M; Lehner HP; Haller J; Langsteger W
    Eur J Radiol; 2009 Mar; 69(3):536-41. PubMed ID: 18248928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
    Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
    Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases: Detection and staging.
    Lincke T; Zech CJ
    Eur J Radiol; 2017 Dec; 97():76-82. PubMed ID: 29153371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls.
    Jha P; Bijan B; Melendres G; Shelton DK
    Clin Nucl Med; 2015 Mar; 40(3):206-13. PubMed ID: 25608151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal malignancy: anatomy, pathophysiology and an update on modern day imaging.
    Power JW; Dempsey PJ; Yates A; Fenlon H; Mulsow J; Shields C; Cronin CG
    Br J Radiol; 2022 Apr; 95(1132):20210217. PubMed ID: 34826229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of the peritoneal spread of malignancy.
    Low RN
    Abdom Imaging; 2007; 32(3):267-83. PubMed ID: 17334873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneal carcinosis in ovarian cancer: conventional imaging (CT-scan and MRI)].
    Bailly C; Bailly-Glatre A; Alfidja A; Vincent C; Dauplat J; Pomel C
    Bull Cancer; 2009 Dec; 96(12):1155-62. PubMed ID: 19959422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applied peritoneal anatomy.
    Patel RR; Planche K
    Clin Radiol; 2013 May; 68(5):509-20. PubMed ID: 23149392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature.
    Virarkar M; Vulasala SS; Calimano-Ramirez L; Singh A; Lall C; Bhosale P
    Curr Oncol; 2023 Jan; 30(1):1077-1105. PubMed ID: 36661732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.